Literature DB >> 14111610

THE USE OF RAT BLADDER POUCHES TO ELUCIDATE THE MODE OF ACTION OF A CHEMICAL WHICH INDUCES HYPERPLASIA IN THE BLADDER EPITHELIUM.

S SANTANA.   

Abstract

Entities:  

Keywords:  BLADDER DISEASES; CARCINOGENS; EPITHELIUM; EXPERIMENTAL LAB STUDY; HYPERTROPHY AND HYPERPLASIA; NAPHTHALENES; PATHOLOGY; PHARMACOLOGY; RATS; SULFONAMIDES; TOXICOLOGIC REPORT; URINE

Mesh：

Substances：

Year:  1963        PMID： 14111610      PMCID： PMC2071227          DOI： 10.1038/bjc.1963.91

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  Tumour-promoting action of 4-ethylsulphonylnaphthalene-1-sulphonamide.

Authors:  K P SEN GUPTA
Journal:  Nature       Date:  1962-06-23       Impact factor: 49.962

2.  The role of corticosteroids in the treatment of malignant lymphomas.

Authors:  S KOFMAN; C P PERLIA; E BOESEN; R EISENSTEIN; S G TAYLOR
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

3.  The treatment of lymphomas with adrenocortical substances.

Authors:  C L SPURR; W L WILSON
Journal:  South Med J       Date:  1955-12       Impact factor: 0.954

4.  The role of the urine in vesical neoplasm. I. Experimental confirmation of the urogenous theory of pathogenesis.

Authors:  D F McDONALD; R R LUND
Journal:  J Urol       Date:  1954-05       Impact factor: 7.450

5.  The effect of cortisone in Hodgkin's disease.

Authors:  B STRAUS; A S JACOBSON; S A BERSON; T C BERNSTEIN; R S FADEM; R S YALOW
Journal:  Am J Med       Date:  1952-02       Impact factor: 4.965

6.  Adrenocorticotropic hormone- and cortisone-induced regression of lymphoid tumors in man; a preliminary report.

Authors:  O H PEARSON; L P ELIEL
Journal:  Cancer       Date:  1949-11       Impact factor: 6.860
  6 in total
  1 in total

1.  THE INDUCTION OF TUMOURS OF THE MOUSE BLADDER EPITHELIUM BY 4-ETHYLSULPHONYLNAPHTHALENE-1-SULPHONAMIDE.

Authors:  D B CLAYSON; G M BONSER
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.